OXELTIS will be at #BIO2026 in San Diego, June 22-25.
We attend as the lead partner of an integrated preclinical R&D consortium, combining medicinal chemistry (OXELTIS, Montpellier), computational CADD/SBDD/GenAI (Molecular Forecaster, Montreal), and preclinical biology (Partex.AI Labs, Regensburg).
If you are exploring hit discovery, H2L, or lead optimization partnerships, we would be glad to connect and discuss how our integrated model can accelerate your program.
You can contact Christophe Parsy or book a meeting via BIO One-on-One Partnering.